- SOXFE achieved high record-disjoint EEG classification accuracy: 92.77% (Stage 2) and 97.00% (Stage 3) using LORO hold-out.
- Pipeline combined LTPat feature extraction, CWNCA training-only selection, tkNN classification, IMV fusion and DLob explanations for traceable decision-making.
- Limitation: single-source dataset and unknown participant linkage may overestimate person-independent performance; verified subject-wise validation required before clinical use.
Technol Health Care. 2026 Oct 10:9287329261495183. doi: 10.1177/09287329261495183. Online ahead of print.
ABSTRACT
BackgroundFibromyalgia is a chronic pain disorder associated with sleep disturbance and substantial functional burden.ObjectiveThis study evaluated a self-organized explainable feature engineering (SOXFE) model for EEG-based fibromyalgia classification.MethodsA previously reported sleep EEG dataset from a 32-participant source cohort was analyzed separately for NREM Stage 2 and Stage 3. The analysis-ready version contained 136 labeled stage-record files: 74 for Stage 2 and 62 for Stage 3. The SOXFE model comprised LTPat feature extraction, training-only CWNCA feature selection, tkNN classification, IMV information fusion, and DLob-based explanation. Record-wise LORO was primary; segment-level 10-fold cross-validation was complementary.ResultsRecord-wise LORO used 74 outer folds for Stage 2 and 62 for Stage 3. Descriptive pooled held-out-epoch accuracy was 92.77% (95% CI: 91.76-93.67) for Stage 2 and 97.00% (95% CI: 96.22-97.63) for Stage 3. Every epoch from the held-out recording was excluded from training and selection. Complementary segment-level 10-fold cross-validation yielded 100.00% accuracy for both stages but was not used as evidence of record-wise generalization.ConclusionsThe model provided record-disjoint classification and traceable model-derived explanations in this single-source dataset. LORO prevented within-record epoch leakage. However, participant linkage was unavailable, so records from the same person may have occurred across outer partitions and the reported values may overestimate person-independent performance. Verified subject-wise validation is required before clinical use.
PMID:42856024 | DOI:10.1177/09287329261495183
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
Save as PDF
⭐ My Revision List

